Inspectors at the US Food and Drug Administration (FDA) say lack of data integrity, transparency, record retention, and inadequate controls are some of the most common issues they see during ...

Officials sanctioned Dabur India months after FDA inspectors found bird droppings and data integrity deficiencies during an ...

The US FDA has issued a Form 483 to Dabur India following an inspection of its Dadra and Nagar Haveli plant. Discover the serious findings, including data integrity lapses, ...

Dabur India Ltd reported a US FDA import alert on drugs from part of its Silvassa plant due to data integrity and maintenance ...

June 11 (Reuters) - The U.S. Food and Drug Administration has issued an import alert for drugs manufactured at Dabur India's ...

The inability to conduct onsite inspections impeded investigators’ ability to uncover data integrity issues at manufacturing sites in drug warning letters in FY2021, underscoring the importance of ...

FDA highlights data integrity and contamination risks at Dabur India's plant, following a January inspection revealing ...

The US FDA has placed drugs made at Dabur India's Dadra and Nagar Haveli factory under import alert after an inspection.

The US FDA has issued Import Alert 66-40 for drugs manufactured at a part of Dabur India’s Silvassa facility after ...

Cathy Burgess, Yifan Wang, Ph.D. Our FDA: Compliance & Enforcement Team examines a new FDA compliance program for Center for Drug Evaluation and Research (CDER)-regulated biologics, highlighting the ...